Pharmacokinetic Properties of Lorcaserin in Subjects With Hepatic Impairment

NCT00828932 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Impairment

Interventions

DRUG: Lorcaserin

Sponsor

Eisai Inc.